Clinical Trial Update: Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating rosiglitazone for locoregionally extensive or metastatic thyroid cancer is described. The sponsor is University of Californi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Thyroid Cancer

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: University of California, San Francisco | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN